SAN DIEGO, Nov. 23, 2020 /PRNewswire/ — Neurana Pharmaceuticals, a biotechnology company focused on the treatment of neuromuscular conditions, today announced the publication of results from the dose-ranging Phase 2 STAR Study of tolperisone in pat… […]
SAN DIEGO, Nov. 23, 2020 /PRNewswire/ — Neurana Pharmaceuticals, a biotechnology company focused on the treatment of neuromuscular conditions, today announced the publication of results from the dose-ranging Phase 2 STAR Study of tolperisone in pat… […]
– Company aims to apply machine learning to large datasets created by this study to identify approaches to increase patient response to existing oncology treatments as well as identify new therapeutic targets — Planned enrollment of 4,000 patients mak… […]
– Raises 2020 Guidance to $265 Million to $275 Million in Revenues, Up from $250 Million to $260 Million, and EPS of $0.90 to $0.95, Up from $0.80 to $0.85 –
SAN DIEGO, Nov. 23, 2020 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) today a… […]
– First-of-its-kind biopharmaceutical manufacturing and technology company broadens access to novel therapies and vaccines while protecting supply chains against disruption.- RESILIENCE will invest heavily in developing powerful new manufacturing techn… […]
Robert Wicke brings comprehensive leadership to innovative start-up
SAN DIEGO, Nov. 20, 2020 /PRNewswire/ — Omniome, Inc., developer of a novel DNA sequencing platform capable of delivering unsurpassed sequencing accuracy, today announces the appoin… […]
SAN DIEGO, Nov. 20, 2020 /PRNewswire/ — Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced it will participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference, taking place virtually November 30 through December 3, 2020.
… […]
SAN DIEGO, Nov. 20, 2020 /PRNewswire/ — Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic assays, products and services designed to provide physicians with clinically actionable information to improve patient outco… […]
SAN DIEGO, Nov. 19, 2020 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that Neurocrine Biosciences management will present at the following investor conferences:
Matt Abernethy, Chief Financial Officer, and Eiry … […]
New CEO joins lateral flow diagnostic developer’s executive team
CARLSBAD, Calif., Nov. 19, 2020 /PRNewswire/ — Martis Capital, a private equity firm focused on the healthcare industry, announced today a growth equity investment in DCN Dx, a lateral… […]
Copyright © 2020 | MH Magazine WordPress Theme by MH Themes
